Leveraging a unique drug discovery platform that identifies and maps novel lipid-binding pockets on proteins, to develop new medicines to treat cancer patients.
Leveraging a unique drug discovery platform that identifies and maps novel lipid-binding pockets on proteins, to develop new medicines to treat cancer patients.
LATEST NEWS
Tasca Therapeutics Doses First Patient in Phase 1/2 Dose Escalation and Expansion Trial Evaluating CP-383 in Advanced Solid Tumors
Tasca Therapeutics Launches with $52 Million Series A Financing to Develop Small Molecule Inhibitors for Multiple Oncology Indications
